Kennedy Capital Management’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$732K Buy
51,491
+4,225
+9% +$54.3K 0.02% 503
2025
Q4
$489K Buy
47,266
+1,255
+3% +$11.3K 0.01% 512
2025
Q3
$273K Buy
46,011
+33,837
+278% +$248K 0.01% 545
2025
Q2
$91.7K Buy
12,174
+531
+5% +$4.27K ﹤0.01% 580
2025
Q1
$88.1K Sell
11,643
-99,406
-90% -$954K ﹤0.01% 641
2024
Q4
$1.35M Buy
+111,049
New +$1.6M 0.03% 564
2024
Q2
Sell
-84,234
Closed -$1.44M 707
2024
Q1
$1.44M Sell
84,234
-75,778
-47% -$1.17M 0.03% 579
2023
Q4
$1.63M Sell
160,012
-329,434
-67% -$2.92M 0.04% 528
2023
Q3
$4.43M Sell
489,446
-52,476
-10% -$547K 0.11% 310
2023
Q2
$5.83M Sell
541,922
-43,020
-7% -$457K 0.14% 265
2023
Q1
$5.98M Sell
584,942
-28,647
-5% -$316K 0.18% 217
2022
Q4
$6.47M Sell
613,589
-25,321
-4% -$308K 0.18% 194
2022
Q3
$8.19M Buy
638,910
+604,563
+1,760% +$8.15M 0.24% 134
2022
Q2
$440K Buy
+34,347
New +$389K 0.01% 552

Other funds holding CGEM